Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia
V Tran Quang, O Wagner-Ballon, I Sloma - Leukemia & Lymphoma, 2024 - Taylor & Francis
The boundary between myelodysplastic syndromes (MDS) and chronic myelomonocytic
leukemia (CMML) has been revised in the latest World Health Organization classification of …
leukemia (CMML) has been revised in the latest World Health Organization classification of …
[HTML][HTML] Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with …
B Xicoy, H Pomares, M Morgades… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Methods We compared CMML with and without RS/SF3B1 and MDS-RS/SF3B1 considering
the criteria established by the 2022 World Health Organization classification. Results A total …
the criteria established by the 2022 World Health Organization classification. Results A total …
Should oligomonocytic CMML be classified as an independent disease entity?
HG Zhao - British Journal of Haematology, 2024 - Wiley Online Library
The 2022 WHO Classification revised the diagnostic criteria of CMML and included the
variant, formerly known as oligomonocytic CMML (O‐CMML), into the CMML disease …
variant, formerly known as oligomonocytic CMML (O‐CMML), into the CMML disease …
Diagnostic challenges and criteria application in a 70-year-old patient with oligo monocytic chronic granulomonocytic leukemia: A case report
X Wang, T Chen - Leukemia research, 2024 - pubmed.ncbi.nlm.nih.gov
Diagnostic challenges and criteria application in a 70-year-old patient with oligo monocytic
chronic granulomonocytic leukemia: A case report Diagnostic challenges and criteria application …
chronic granulomonocytic leukemia: A case report Diagnostic challenges and criteria application …